The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 12, 2018

Filed:

Jul. 23, 2014
Applicant:

California Institute of Technology, Pasadena, CA (US);

Inventors:

David Baltimore, Pasadena, CA (US);

Pin Wang, Arcadia, CA (US);

Lili Yang, Arcadia, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); C12N 15/867 (2006.01); C07K 14/18 (2006.01); C07K 16/18 (2006.01); C12N 15/86 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C07K 16/2887 (2013.01); A61K 2039/505 (2013.01); C07K 2317/53 (2013.01); C07K 2317/622 (2013.01); C07K 2319/00 (2013.01); C07K 2319/03 (2013.01); C12N 2740/15043 (2013.01); C12N 2740/16043 (2013.01); C12N 2740/16045 (2013.01); C12N 2799/027 (2013.01); C12N 2810/80 (2013.01); C12N 2810/851 (2013.01); C12N 2810/859 (2013.01);
Abstract

Methods and compositions are provided for delivering a polynucleotide encoding a gene of interest to a target cell using a virus. The virus envelope comprises a cell-specific binding determinant that recognizes and binds to a component on the target cell surface, leading to endocytosis of the virus. A separate fusogenic molecule is also present on the envelope and facilitates delivery of the polynucleotide across the membrane and into the cytosol of the target cell. The methods and related compositions can be used for treating patients having suffering from a wide range of conditions, including infection, such as HIV; cancers, such as non-Hodgkin's lymphoma and breast cancer; and hematological disorders, such as severe combined immunodeficiency.


Find Patent Forward Citations

Loading…